Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 246 Precursor Cell Lymphoblastic Leukemia-Lymphoma 147 Myelodysplastic Syndromes 144 Leukemia, Lymphocytic, Chronic, B-Cell 140 Leukemia 128 Multiple Myeloma 118 Lymphoma 116 Lymphoma, Non-Hodgkin 112 Recurrence 80 Hematologic Neoplasms 77 Melanoma 68 Hodgkin Disease 68 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67 Lymphoma, B-Cell 61 Lymphoma, Mantle-Cell 52 Lymphoma, Large B-Cell, Diffuse 50 Lymphoma, Follicular 50 Burkitt Lymphoma 41 Ovarian Neoplasms 40 Neoplasms 39 Myeloproliferative Disorders 39 Neoplasm Metastasis 34 Lymphoma, B-Cell, Marginal Zone 30 Graft vs Host Disease 29 Neoplasms, Plasma Cell 28 Carcinoma, Non-Small-Cell Lung 27 Breast Neoplasms 27 Leukemia, Biphenotypic, Acute 25 Primary Myelofibrosis 24 Anemia, Refractory, with Excess of Blasts 23

Interventions

Injections 4 Granulocyte-Macrophage Colony-Stimulating Factor 2 Colony-Stimulating Factors 2 nabiximols 1 fludarabine 1 camrelizumab 1 Radiofrequency Ablation 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 Cyclophosphamide 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Malignant Solid Tumor × fludarabine × Clear all

NCT03171220 2017-06-06

NRT-01

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 1/2 Unknown

Other solid neoplasm

Advanced Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡